A Q1 2020 Earnings — Agilent Technologies, Inc. Revenue & Financial Results | Market Cap Arena

AAgilent Technologies, Inc.

$32B

Q1 2020 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$1.4B+5.7% YoY

Gross Profit

$723M53.3% margin

Operating Income

$215M15.8% margin

Net Income

$197M14.5% margin

EPS (Diluted)

$0.63

QoQ Revenue Growth

-0.7%

Cash Flow

Operating Cash Flow

-$59M

Free Cash Flow

-$93M

Stock-Based Comp.

$27M

Balance Sheet

Total Assets

$9.5B

Total Liabilities

$4.7B

Stockholders' Equity

$4.8B

Cash & Equivalents

$1.2B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1.4B	$1.3B	+5.7%
Gross Profit	$723M	$707M	+2.3%
Operating Income	$215M	$250M	-14.0%
Net Income	$197M	$504M	-60.9%

Revenue Segments

Life Sciences and Applied Markets

$638M47%

Agilent CrossLab

$470M35%

Diagnostics and Genomics

$249M18%

Geographic Segments

Americas

$494M36%

Asia Pacific

$471M35%

Europe

$392M29%